New markers of cardio-renal links in chronic kidney disease

• Main Authors: L Iu Milovanova, Iu S Milovanov, L V Kozlovskaia, N A Mukhin
• Format: Article
• Language: Russian
• Published: "Consilium Medicum" Publishing house 2013-06-01
• Series: Терапевтический архив
• Subjects: chronic kidney disease; hemodialysis; fibroblast growth factor (fgf-23); klotho; arterial hypertension; anemia; phosphorus and calcium metabolism dis turbances; secondary hyperparathyroidism
• Online Access: https://ter-arkhiv.ru/0040-3660/article/view/31266
• ISSN: 0040-3660; 2309-5342

AIM: To study the clinical significance of determining the serum concentration of phosphorus and calcium metabolism regulators - the morphogenetic proteins FGF-23 and Klotho in patients with different stages of chronic kidney disease (CKD)/MATERIAL AND METHODS: The serum levels of FGF-23 (a human FGF-23 ELISA kit with full-length anti-FGF-23 monoclonal antibodies) and Klotho (a human alpha-K1 ELISA with anti-Klotno antibodies) were investigated in 70 patients with Stages I-VD CKD (41 patients with chronic glomerulonephritis, including 10 with nephritis in systemic diseases, 22 with tubulointerstitial nephritis, and 7 with hypertensive nephroslerosis). The morphogenetic proteins were studied by the specialists of the LiTECH diagnostic laboratory according to the standard protocol/RESULTS: As CKD progressed from Stage I to VD, there were increased FGF-23 concentrations and decreased Klotho levels in the examinees' serum. The highest FGF-23 level and low Klotho concentration were noted in the group of patients on regular hemodialysis treatment (Stage VD). There was a strong inverse correlation between Klotho levels and proteinuria, C-reactive protein, and protein-energy insufficiency, which suggests that these factors influence the serum level of Klotho. The serum levels of FGF-23 and intact parathyroid hormone correlated with these values to a lesser degree. Analysis of the content of the morphogenetic proteins in patients with anemia versus those with CKD of the same stages and target hemoglobin values revealed low Klotho concentrations and high FGF-23 levels (r=0.602; p